-
1
-
-
70349214906
-
EAACI/GA2LEN/EDF guideline: Definition, classification and diagnosis of urticaria
-
T. Zuberbier, R. Asero, C. Bindslev- Jensen, C.G. Walter, M.K. Church, and A. Giménez-Arnau et al. EAACI/GA2LEN/EDF guideline: Definition, classification and diagnosis of urticaria Allergy 64 2009 1417 1426
-
(2009)
Allergy
, vol.64
, pp. 1417-1426
-
-
Zuberbier, T.1
Asero, R.2
Bindslev- Jensen, C.3
Walter, C.G.4
Church, M.K.5
Giménez-Arnau, A.6
-
2
-
-
6344269543
-
Epidemiology of urticaria in Spain
-
P. Gaig, M. Olona, D. Muñoz-Lejarazu, M.T. Caballero, F.J. Domínguez, and S. Echechipia et al. Epidemiology of urticaria in Spain J Invest Allergol Clin Inmunol 14 2004 214 220
-
(2004)
J Invest Allergol Clin Inmunol
, vol.14
, pp. 214-220
-
-
Gaig, P.1
Olona, M.2
Muñoz-Lejarazu, D.3
Caballero, M.T.4
Domínguez, F.J.5
Echechipia, S.6
-
3
-
-
79551682047
-
Unmet clinical needs in chronic spontaneous urticarial. A GA2LEN task force report
-
M. Maurer, K. Weller, C. Bindslev- Jensen, A. Giménez-Arnau, P.J. Bousquet, and G.W. Canonica et al. Unmet clinical needs in chronic spontaneous urticarial. A GA2LEN task force report Allergy 66 2011 317 330
-
(2011)
Allergy
, vol.66
, pp. 317-330
-
-
Maurer, M.1
Weller, K.2
Bindslev- Jensen, C.3
Giménez-Arnau, A.4
Bousquet, P.J.5
Canonica, G.W.6
-
4
-
-
70349210289
-
EAACI/GA2LEN/EDF/WAO guideline: Management of urticaria
-
T. Zuberbier, R. Asero, C. Bindslev-Jensen, G. Walter Canonica, M.K. Church, and A.M. Gimenez-Arnau et al. EAACI/GA2LEN/EDF/WAO guideline: Management of urticaria Allergy 64 2009 1427 1443
-
(2009)
Allergy
, vol.64
, pp. 1427-1443
-
-
Zuberbier, T.1
Asero, R.2
Bindslev-Jensen, C.3
Walter Canonica, G.4
Church, M.K.5
Gimenez-Arnau, A.M.6
-
5
-
-
0027244256
-
Humanization of an antibody directed against IgE
-
L.G. Presta, S.J. Lahr, R.L. Shields, J.P. Porter, C.M. Gorman, and B.M. Fendly et al. Humanization of an antibody directed against IgE J Inmunol 151 1993 2623 2632
-
(1993)
J Inmunol
, vol.151
, pp. 2623-2632
-
-
Presta, L.G.1
Lahr, S.J.2
Shields, R.L.3
Porter, J.P.4
Gorman, C.M.5
Fendly, B.M.6
-
6
-
-
0028143496
-
The binding site on human immunoglobulin e for its high affinity receptor
-
L. Presta, R. Shields, L. O'Connell, S. Lahr, J. Porter, and C. Gorman et al. The binding site on human immunoglobulin E for its high affinity receptor J Biol Chem 269 1994 26368 26373
-
(1994)
J Biol Chem
, vol.269
, pp. 26368-26373
-
-
Presta, L.1
Shields, R.2
O'Connell, L.3
Lahr, S.4
Porter, J.5
Gorman, C.6
-
7
-
-
33947420879
-
Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE omalizumab
-
I. Mirkina, T. Schweighoffer, and F. Kricek Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE omalizumab Inmmunol Lett 109 2007 120 128
-
(2007)
Inmmunol Lett
, vol.109
, pp. 120-128
-
-
Mirkina, I.1
Schweighoffer, T.2
Kricek, F.3
-
8
-
-
78651483333
-
Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
-
M. Saavedra, and S. Sur Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab Clin Mol Allergy 9 2011 2
-
(2011)
Clin Mol Allergy
, vol.9
, pp. 2
-
-
Saavedra, M.1
Sur, S.2
-
9
-
-
0018193792
-
IgE receptor on human basophils: Relationship to serum IgE concentration
-
F. Malveaux, M. Conroy, N. Adkinson, and L. Lichtenstein IgE receptor on human basophils: Relationship to serum IgE concentration J Clin Invest 62 1978 176 181
-
(1978)
J Clin Invest
, vol.62
, pp. 176-181
-
-
Malveaux, F.1
Conroy, M.2
Adkinson, N.3
Lichtenstein, L.4
-
10
-
-
0032012867
-
In vitro regulation of Fc (epsilon)RI expression on human basophils by IgE antibody
-
D. MacGlashan Jr., J. McKenzie-White, K. Chichester, B.S. Boschner, D.C. Adelman, and P.M. Jardieu et al. In vitro regulation of Fc (epsilon)RI expression on human basophils by IgE antibody Blood 91 1998 1633 1643
-
(1998)
Blood
, vol.91
, pp. 1633-1643
-
-
MacGlashan, Jr.D.1
McKenzie-White, J.2
Chichester, K.3
Boschner, B.S.4
Adelman, D.C.5
Jardieu, P.M.6
-
11
-
-
1142309487
-
Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils
-
H. Lin, K.M. Boesel, D.T. Griffith, C. Prussin, B. Foster, and F.A. Romero et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils J Allergy ClinImmunol 113 2004 297 302
-
(2004)
J Allergy ClinImmunol
, vol.113
, pp. 297-302
-
-
Lin, H.1
Boesel, K.M.2
Griffith, D.T.3
Prussin, C.4
Foster, B.5
Romero, F.A.6
-
12
-
-
79960694270
-
T cell activity in successful treatment of chronic urticaria with omalizumab
-
I. Sánchez-Machín, J. Iglesias-Souto, A. Franco, Y. Barrios, R. Gonzalez, and V. Matheu T cell activity in successful treatment of chronic urticaria with omalizumab Clin Mol Allergy 9 2011 11
-
(2011)
Clin Mol Allergy
, vol.9
, pp. 11
-
-
Sánchez-Machín, I.1
Iglesias-Souto, J.2
Franco, A.3
Barrios, Y.4
Gonzalez, R.5
Matheu, V.6
-
13
-
-
77954362538
-
Immunological effects of omalizumab in chronic urticaria: A case report
-
E. Iemoli, S. Piconi, A. Fusi, L. Borgonovo, M. Borelli, and D. Trabattoni Immunological effects of omalizumab in chronic urticaria: A case report J Invest Allergol Clin Immunol 20 2010 252 254
-
(2010)
J Invest Allergol Clin Immunol
, vol.20
, pp. 252-254
-
-
Iemoli, E.1
Piconi, S.2
Fusi, A.3
Borgonovo, L.4
Borelli, M.5
Trabattoni, D.6
-
14
-
-
0034881877
-
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
-
M. Soler, J. Matz, R. Townley, R. Buhl, J. O'Brien, and H. Fox et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Resp J 18 2001 254 261
-
(2001)
Eur Resp J
, vol.18
, pp. 254-261
-
-
Soler, M.1
Matz, J.2
Townley, R.3
Buhl, R.4
O'Brien, J.5
Fox, H.6
-
15
-
-
0141570710
-
Pharmacodynamics of omalizumab: Implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma
-
G. Hochhaus, L. Brookman, H. Fox, C. Johnson, J. Matthews, and S. Ren et al. Pharmacodynamics of omalizumab: Implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma Curr Med Res Opin 19 2003 491 498
-
(2003)
Curr Med Res Opin
, vol.19
, pp. 491-498
-
-
Hochhaus, G.1
Brookman, L.2
Fox, H.3
Johnson, C.4
Matthews, J.5
Ren, S.6
-
16
-
-
63449094824
-
Anti-IgE therapy
-
N.F.J. Adkinson, B.S. Bochner, W. Busse, S. Holgate, R.F.J. Lemanske, F.E.R. Simons, 7th ed. Mosby Elsevier Philadelphia
-
J. Stokes, and T.B. Casale Anti-IgE therapy N.F.J. Adkinson, B.S. Bochner, W. Busse, S. Holgate, R.F.J. Lemanske, F.E.R. Simons, Middleton's allergy principes and practice 7th ed. 2009 Mosby Elsevier Philadelphia 1679 1689
-
(2009)
Middleton's Allergy Principes and Practice
, pp. 1679-1689
-
-
Stokes, J.1
Casale, T.B.2
-
17
-
-
0043240429
-
Evaluation of long-term safety of the anti-IgE antibody, omalizumab in children with allergic asthma
-
W. Berger, N. Gupta, M. McAlary, and A. Fowler-Taylor Evaluation of long-term safety of the anti-IgE antibody, omalizumab in children with allergic asthma Ann Allergy Asthma Inmmunol 91 2003 182 188
-
(2003)
Ann Allergy Asthma Inmmunol
, vol.91
, pp. 182-188
-
-
Berger, W.1
Gupta, N.2
McAlary, M.3
Fowler-Taylor, A.4
-
18
-
-
36749096427
-
American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology Report on omalizumab-associated anaphilaxis
-
L. Cox, P. Lieberman, D. Wallace, F.E. Simons, I. Finegold, and T. Platts-Mills et al. American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology Report on omalizumab-associated anaphilaxis J Allergy Clin Inmmunol 120 2007 1373 1377
-
(2007)
J Allergy Clin Inmmunol
, vol.120
, pp. 1373-1377
-
-
Cox, L.1
Lieberman, P.2
Wallace, D.3
Simons, F.E.4
Finegold, I.5
Platts-Mills, T.6
-
19
-
-
79959821554
-
American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology. Omalizumab-Associated Anaphilaxis Joint Task Force follow-up report
-
L. Cox, P. Lieberman, D. Wallace, F.E. Simons, I. Finegold, and T. Platts-Mills et al. American Academy of Allergy, Asthma and Inmmunology/American College of Allergy, Asthma and Inmmunology. Omalizumab-Associated Anaphilaxis Joint Task Force follow-up report J Allergy Clin Inmmunol 128 2011 210 212
-
(2011)
J Allergy Clin Inmmunol
, vol.128
, pp. 210-212
-
-
Cox, L.1
Lieberman, P.2
Wallace, D.3
Simons, F.E.4
Finegold, I.5
Platts-Mills, T.6
-
20
-
-
26444439970
-
®), a recombinant humanized monoclonal anti-IgE antibody
-
®), a recombinant humanized monoclonal anti-IgE antibody Clin Rev Allergy Immunol 29 2005 31 48
-
(2005)
Clin Rev Allergy Immunol
, vol.29
, pp. 31-48
-
-
Deniz, Y.M.1
Gupta, N.2
-
21
-
-
84862820922
-
Omalizumab and the risk of malignancy: Results from a pooled analysis
-
W. Busse, R. Buhl, C. Fernandez Vidaurre, M. Blogg, J. Zhu, and M.D. Eisner et al. Omalizumab and the risk of malignancy: Results from a pooled analysis J Allergy Clin Immunol 129 2012 983 989
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 983-989
-
-
Busse, W.1
Buhl, R.2
Fernandez Vidaurre, C.3
Blogg, M.4
Zhu, J.5
Eisner, M.D.6
-
22
-
-
70349445071
-
Baseline characteristics of patients enrolled in EXCELS: A cohort study
-
A.A. Long, J.E. Fish, A. Rahmaoui, M.K. Miller, M.S. Bradley, and H.N. Taki et al. Baseline characteristics of patients enrolled in EXCELS: A cohort study Ann Allergy Asthma Immunol 103 2009 212 219
-
(2009)
Ann Allergy Asthma Immunol
, vol.103
, pp. 212-219
-
-
Long, A.A.1
Fish, J.E.2
Rahmaoui, A.3
Miller, M.K.4
Bradley, M.S.5
Taki, H.N.6
-
23
-
-
33646947344
-
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
-
J.A. Boyce Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE J Allergy Clin Immunol 117 2006 1415 1418
-
(2006)
J Allergy Clin Immunol
, vol.117
, pp. 1415-1418
-
-
Boyce, J.A.1
-
24
-
-
34547944181
-
Effect of omalizumab on patients with chronic urticaria
-
S.L. Spector, and R.A. Tan Effect of omalizumab on patients with chronic urticaria Ann Allergy Asthma Immunol 99 2007 190 193
-
(2007)
Ann Allergy Asthma Immunol
, vol.99
, pp. 190-193
-
-
Spector, S.L.1
Tan, R.A.2
-
25
-
-
53749100152
-
Successful treatment of solar urticaria with anti-immunoglobulin e therapy
-
O. Güzelbey, E. Ardelean, M. Magerl, T. Zuberbier, M. Maurer, and M. Metz Successful treatment of solar urticaria with anti-immunoglobulin E therapy Allergy 63 2008 1563 1565
-
(2008)
Allergy
, vol.63
, pp. 1563-1565
-
-
Güzelbey, O.1
Ardelean, E.2
Magerl, M.3
Zuberbier, T.4
Maurer, M.5
Metz, M.6
-
26
-
-
80052872083
-
Omalizumab in treatment-resistant chronic spontaneous urticaria
-
K.V. Godse Omalizumab in treatment-resistant chronic spontaneous urticaria Indian J Dermatol 56 2011 444
-
(2011)
Indian J Dermatol
, vol.56
, pp. 444
-
-
Godse, K.V.1
-
27
-
-
37749011236
-
Successful treatment of cholinergic urticaria with anti-immunoglobulin e therapy
-
M. Metz, P. Bergmann, T. Zuberbier, and M. Maurer Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy Allergy 63 2008 247 249
-
(2008)
Allergy
, vol.63
, pp. 247-249
-
-
Metz, M.1
Bergmann, P.2
Zuberbier, T.3
Maurer, M.4
-
28
-
-
68249146545
-
A case of severe refractory chronic urticaria: A novel method for evaluation and treatment
-
H.F. Otto, and C.W. Calabria A case of severe refractory chronic urticaria: A novel method for evaluation and treatment Allergy Asthma Proc 30 2009 333 337
-
(2009)
Allergy Asthma Proc
, vol.30
, pp. 333-337
-
-
Otto, H.F.1
Calabria, C.W.2
-
29
-
-
77956394970
-
Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab
-
M. Magerl, P. Staubach, S. Altrichter, E. Ardelean, K. Krause, and M. Metz et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab J Allergy Clin Immunol 126 2010 665 666
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 665-666
-
-
Magerl, M.1
Staubach, P.2
Altrichter, S.3
Ardelean, E.4
Krause, K.5
Metz, M.6
-
30
-
-
77954941791
-
Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab
-
C. Vestergaard, and M. Deleuran Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab Acta Derm Venereol 90 2010 443 444
-
(2010)
Acta Derm Venereol
, vol.90
, pp. 443-444
-
-
Vestergaard, C.1
Deleuran, M.2
-
31
-
-
78649260196
-
Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin e therapy
-
K. Krause, E. Ardelean, B. Kessler, M. Magerl, M. Metz, and F. Siebenhaar et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy Allergy 65 2010 1494 1495
-
(2010)
Allergy
, vol.65
, pp. 1494-1495
-
-
Krause, K.1
Ardelean, E.2
Kessler, B.3
Magerl, M.4
Metz, M.5
Siebenhaar, F.6
-
33
-
-
76749153779
-
Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria
-
C. Romano, A. Sellitto, U. de Fanis, G. Esposito, P. Arbo, and R. Giunta et al. Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria Ann Allergy Asthma Immunol 104 2010 95 97
-
(2010)
Ann Allergy Asthma Immunol
, vol.104
, pp. 95-97
-
-
Romano, C.1
Sellitto, A.2
De Fanis, U.3
Esposito, G.4
Arbo, P.5
Giunta, R.6
-
34
-
-
77953111313
-
Effective treatment of refractory severe heat urticaria with omalizumab
-
U. Bullerkotte, D. Wieczorek, A. Kapp, and B. Wedi Effective treatment of refractory severe heat urticaria with omalizumab Allergy 65 2010 931 932
-
(2010)
Allergy
, vol.65
, pp. 931-932
-
-
Bullerkotte, U.1
Wieczorek, D.2
Kapp, A.3
Wedi, B.4
-
35
-
-
77951241500
-
Failure of omalizumab in cholinergic urticaria
-
R.A. Sabroe Failure of omalizumab in cholinergic urticaria Clin Exp Dermatol 35 2010 e127 e129
-
(2010)
Clin Exp Dermatol
, vol.35
-
-
Sabroe, R.A.1
-
36
-
-
72049102902
-
Efficacy of omalizumab in delayed pressure urticaria: A case report
-
C. Bindslev-Jensen, and P.S. Skov Efficacy of omalizumab in delayed pressure urticaria: A case report Allergy 65 2010 138 139
-
(2010)
Allergy
, vol.65
, pp. 138-139
-
-
Bindslev-Jensen, C.1
Skov, P.S.2
-
37
-
-
78649383197
-
Omalizumab therapy in three patients with chronic autoimmune urticaria
-
M. Al-Ahmad Omalizumab therapy in three patients with chronic autoimmune urticaria Ann Saudi Med 30 2010 478 481
-
(2010)
Ann Saudi Med
, vol.30
, pp. 478-481
-
-
Al-Ahmad, M.1
-
38
-
-
78651096597
-
Omalizumab - An effective and safe treatment of therapy-resistant chronic spontaneous urticaria
-
A. Groffik, H. Mitzel-Kaoukhov, M. Magerl, M. Maurer, and P. Staubach Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria Allergy 66 2011 303 305
-
(2011)
Allergy
, vol.66
, pp. 303-305
-
-
Groffik, A.1
Mitzel-Kaoukhov, H.2
Magerl, M.3
Maurer, M.4
Staubach, P.5
-
39
-
-
77956078962
-
Anti-immunoglobulin e treatment of patients with recalcitrant physical urticaria
-
M. Metz, S. Altrichter, E. Ardelean, B. Kessler, K. Krause, and M. Magerl et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria Int Arch Allergy Immunol 154 2011 177 180
-
(2011)
Int Arch Allergy Immunol
, vol.154
, pp. 177-180
-
-
Metz, M.1
Altrichter, S.2
Ardelean, E.3
Kessler, B.4
Krause, K.5
Magerl, M.6
-
41
-
-
84859799340
-
Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
-
S. Büyüköztürk, A. Gelincik, M. Demirtürk, E. Kocaturk, B. Colakoǧlu, and M. Dal Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey J Dermatol 39 2012 439 442
-
(2012)
J Dermatol
, vol.39
, pp. 439-442
-
-
Büyüköztürk, S.1
Gelincik, A.2
Demirtürk, M.3
Kocaturk, E.4
Colakoǧlu, B.5
Dal, M.6
-
42
-
-
84860776801
-
Omalizumab for chronic urticaria: A case series and overview of the literature
-
I. Ivyanskiy, C. Sand, and S.T. Francis Omalizumab for chronic urticaria: A case series and overview of the literature Case Rep Dermatol 4 2012 19 26
-
(2012)
Case Rep Dermatol
, vol.4
, pp. 19-26
-
-
Ivyanskiy, I.1
Sand, C.2
Francis, S.T.3
-
43
-
-
50649084564
-
Treatment of chronic autoimmune urticarial with omalizumab
-
A.P. Kaplan, K. Joseph, R.J. Mayjut, G.P. Geba, and R.K. Zeldin Treatment of chronic autoimmune urticarial with omalizumab J Allergy Clin Inmmunol 122 2008 569 573
-
(2008)
J Allergy Clin Inmmunol
, vol.122
, pp. 569-573
-
-
Kaplan, A.P.1
Joseph, K.2
Mayjut, R.J.3
Geba, G.P.4
Zeldin, R.K.5
-
44
-
-
79955575746
-
Omalizumab is effective in non autoimmune urticaria
-
M. Ferrer, P. Gamboa, M.L. Sanz, M.J. Goikoetxea, P. Cabrera-Freitag, and G. Javaloyes et al. Omalizumab is effective in non autoimmune urticaria J Allergy Clin Immunol 127 2011 1300 1302
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 1300-1302
-
-
Ferrer, M.1
Gamboa, P.2
Sanz, M.L.3
Goikoetxea, M.J.4
Cabrera-Freitag, P.5
Javaloyes, G.6
-
45
-
-
79959855552
-
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
-
M. Maurer, S. Altrichter, T. Bieber, T. Biedermann, M. Bräutigam, and S. Seyfried et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase J Allergy Clin Inmmunol 128 2011 202 209
-
(2011)
J Allergy Clin Inmmunol
, vol.128
, pp. 202-209
-
-
Maurer, M.1
Altrichter, S.2
Bieber, T.3
Biedermann, T.4
Bräutigam, M.5
Seyfried, S.6
-
46
-
-
80052299857
-
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
-
S. Saini, K.E. Rosen, H.J. Hsieh, D.A. Wong, E. Conner, and A. Kaplan et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria J Allergy Clin Inmmunol 128 2011 567 573
-
(2011)
J Allergy Clin Inmmunol
, vol.128
, pp. 567-573
-
-
Saini, S.1
Rosen, K.E.2
Hsieh, H.J.3
Wong, D.A.4
Conner, E.5
Kaplan, A.6
|